The most anticipated COVID-19 vaccine finally arrived in Jakarta and it was immediately taken to the headquarters of the state-owned pharmaceutical company Bio Farma in Bandung, West Java, where it is now being kept under tight military and police guard. Indonesia has obtained 1.2 million doses of the CoronaVac vaccine from Sinovac Biotech Ltd, a biopharmaceutical corporation headquartered in Beijing, …

Minister of State-Owned Enterprises (SOEs) and Chief Executive of the Committee for Handling COVID-19 and Economic Recovery (PCPEN), Erick Thohir, hope that in 2022 the Merah Putih vaccine can start to be produced. “From the information obtained, God willing, clinical trials I to III of the Red and White vaccine can run next year so that in 2022 we can …

PT Bio Farma (Persero) will receive 50 million doses of the Covid-19 Ready to Fill (RTF) vaccine bulk or concentrate from the Chinese biopharmaceutical company, Sinovac from November 2020 to March 2021. This assurance was marked by the signing of the Preliminary Agreement of Purchase and Supply of Bulk Production of Covid-19 Vaccine, which was held in Hainan, China on …

Apart from working with other countries in developing the coronavirus vaccine (Covid-19), Indonesia is also developing vaccines independently. The domestically made vaccine is called Merah Putih Vaccine. PT Bio Farma’s Project Integration Management Research and Development Neni Nurainy said that the Merah Putih vaccine would be a long-term strategy. “Indonesia with 270 million people must be ready with its own …

Holding SOEs Pharmacy, PT Bio Farma (Persero) on Thursday (8/6), has started clinical trials of the Covid-19 vaccine in collaboration with a biotechnology company from China, Sinovac. This clinical trial is scheduled to last for 6 months. In carrying out the trial, as many as 1,620 people, with a vulnerable age 18-59 will be taken as samples. Bio Farma collaborates …